<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dose intensity of selected conditioning regimens used for allogeneic hematopoietic cell transplantation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dose intensity of selected conditioning regimens used for allogeneic hematopoietic cell transplantation</h1>
<div class="graphic"><div class="figure"><div class="ttl">Dose intensity of selected conditioning regimens used for allogeneic hematopoietic cell transplantation</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">BU: busulfan; CY: cyclophosphamide; TBI: total body irradiation; Flu: fludarabine (various dosing schedules); AraC: cytosine arabinoside; ATG: antithymocyte globulin (or thymoglobulin); 131I: anti-CD45 antibody conjugated to 131I; GVT: graft versus tumor.<br/>* "High-dose" TBI (800 to 1320 cGy).<br/><font class="bullet">•</font> "Low-dose" TBI (200 to 400 cGy).</div><div class="graphic_reference">This research was originally published in Blood. Deeg HJ, Sandmaier BM. Who is fit for allogeneic transplantation? Blood 2010; 116:4762. Copyright © 2010 American Society of Hematology.</div><div id="graphicVersion">Graphic 87814 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
